- Home
- BDRX vs PRFX Comparison
BDRX vs PRFX Comparison
Compare BDRX & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- PRFX
- Stock Information
- Founded
- BDRX 2000
- PRFX 2007
- Country
- BDRX United Kingdom
- PRFX Israel
- Employees
- BDRX N/A
- PRFX N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- BDRX Health Care
- PRFX Health Care
- Exchange
- BDRX Nasdaq
- PRFX Nasdaq
- Market Cap
- BDRX 3.6M
- PRFX 3.6M
- IPO Year
- BDRX N/A
- PRFX 2020
- Fundamental
- Price
- BDRX $1.15
- PRFX $2.06
- Analyst Decision
- BDRX
- PRFX Hold
- Analyst Count
- BDRX 0
- PRFX 1
- Target Price
- BDRX N/A
- PRFX N/A
- AVG Volume (30 Days)
- BDRX 3.6M
- PRFX 55.9K
- Earning Date
- BDRX 04-11-2025
- PRFX 06-20-2025
- Dividend Yield
- BDRX N/A
- PRFX N/A
- EPS Growth
- BDRX N/A
- PRFX N/A
- EPS
- BDRX N/A
- PRFX N/A
- Revenue
- BDRX N/A
- PRFX N/A
- Revenue This Year
- BDRX N/A
- PRFX N/A
- Revenue Next Year
- BDRX N/A
- PRFX N/A
- P/E Ratio
- BDRX N/A
- PRFX N/A
- Revenue Growth
- BDRX N/A
- PRFX N/A
- 52 Week Low
- BDRX $1.01
- PRFX $1.68
- 52 Week High
- BDRX $41.50
- PRFX $18.17
- Technical
- Relative Strength Index (RSI)
- BDRX 39.66
- PRFX 51.59
- Support Level
- BDRX $1.01
- PRFX $1.93
- Resistance Level
- BDRX $1.26
- PRFX $2.11
- Average True Range (ATR)
- BDRX 0.12
- PRFX 0.10
- MACD
- BDRX 0.01
- PRFX 0.03
- Stochastic Oscillator
- BDRX 15.22
- PRFX 80.77
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.